Daniel Reiton

Daniel Reiton is a skilled scientist with a strong background in biology and a focus on cancer therapeutics. Currently serving as a Scientist and previously as an Associate Scientist at Cartography Biosciences since February 2023, Daniel specializes in growing and characterizing CAR-T cells. Prior experience includes a role as Senior Research Associate I in In Vitro Pharmacology at Maze Therapeutics from June 2019 to December 2021, and serving as Associate Scientist II at Stemcentrx, Inc. from July 2016 to April 2019. Daniel holds a Bachelor of Science degree in Biology from UC Santa Barbara, earned in 2016.